San Francisco Sentry Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$494K Sell
6,355
-1,266
-17% -$94.2K 0.26% 112
2021
Q1
$560K Sell
7,621
-632
-8% -$46.6K 0.24% 115
2020
Q4
$644K Hold
8,253
0.3% 91
2020
Q3
$654K Sell
8,253
-10
-0.1% -$783 0.34% 82
2020
Q2
$610K Sell
8,263
-2,105
-20% -$158K 0.32% 84
2020
Q1
$761K Sell
10,368
-3,567
-26% -$280K 0.48% 45
2019
Q4
$1.21M Sell
13,935
-10,396
-43% -$854K 0.54% 38
2019
Q3
$1.95M Buy
24,331
+106
+0.4% +$8.49K 0.9% 26
2019
Q2
$1.94M Sell
24,225
-1,569
-6% -$120K 0.89% 26
2019
Q1
$2.05M Buy
25,794
+174
+0.7% +$13K 0.88% 25
2018
Q4
$1.87M Buy
25,620
+178
+0.7% +$12.6K 0.88% 21
2018
Q3
$1.72M Buy
25,442
+249
+1% +$15.9K 0.64% 32
2018
Q2
$1.46M Sell
25,193
-3,099
-11% -$175K 0.61% 29
2018
Q1
$1.47M Buy
28,292
+1,929
+7% +$104K 0.42% 48
2017
Q4
$1.42M Buy
26,363
+927
+4% +$51.4K 0.41% 47
2017
Q3
$1.55M Buy
25,436
+3,136
+14% +$190K 0.52% 43
2017
Q2
$1.36M Buy
22,300
+10,265
+85% +$625K 0.49% 48
2017
Q1
$729K Sell
12,035
-208
-2% -$12.6K 0.4% 74
2016
Q4
$688K Buy
12,243
+1,078
+10% +$63.1K 0.4% 75
2016
Q3
$665K Sell
11,165
-150
-1% -$8.77K 0.39% 78
2016
Q2
$622K Sell
11,315
-571
-5% -$30.4K 0.38% 82
2016
Q1
$600K Buy
11,886
+2,189
+23% +$107K 0.36% 77
2015
Q4
$489K Buy
9,697
+479
+5% +$24.1K 0.31% 88
2015
Q3
$434K Sell
9,218
-1,158
-11% -$61.5K 0.31% 90
2015
Q2
$564K Buy
10,376
+293
+3% +$16.4K 0.34% 84
2015
Q1
$553K Buy
10,083
+332
+3% +$18.8K 0.33% 83
2014
Q4
$528K Sell
9,751
-330
-3% -$18.4K 0.31% 85
2014
Q3
$570K Sell
10,081
-312
-3% -$17.5K 0.29% 85
2014
Q2
$574K Sell
10,393
-89
-0.8% -$4.86K 0.28% 89
2014
Q1
$568K Sell
10,482
-665
-6% -$34.4K 0.18% 119
2013
Q4
$532K Buy
11,147
+149
+1% +$6.81K 0.18% 119
2013
Q3
$500K Sell
10,998
-84
-0.8% -$3.83K 0.19% 121
2013
Q2
$491K Buy
+11,082
New +$495K 0.18% 118

Other funds holding MRK

San Francisco Sentry Investment Group's MRK Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Merck (MRK) stake by 17% in Q2 2021, selling an estimated $94.2K and leaving 6,355 shares worth $494K. The position accounts for 0.26% of the portfolio, ranked #112.

San Francisco Sentry Investment Group first reported a position in MRK in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.05M in Q1 2019. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • San Francisco Sentry Investment Group held 6,355 shares of Merck worth $494K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 1,266 Merck shares in Q2 2021, an estimated $94.2K.
  • Merck made up 0.26% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #112 holding.
  • San Francisco Sentry Investment Group first reported a position in Merck in Q2 2013 and has held it in 33 quarters since.
  • San Francisco Sentry Investment Group's Merck position peaked at $2.05M in Q1 2019.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.